These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 35048789)
21. Clinical characteristics and risk factors for overlapping rheumatoid arthritis and Sjögren's syndrome. Yang H; Bian S; Chen H; Wang L; Zhao L; Zhang X; Zhao Y; Zeng X; Zhang F Sci Rep; 2018 Apr; 8(1):6180. PubMed ID: 29670135 [TBL] [Abstract][Full Text] [Related]
22. Primary Sjögren's syndrome with diffuse cystic lung changes developed systemic lupus erythematosus: a case report and literature review. Liu X; Li H; Yin Y; Ma D; Qu Y Oncotarget; 2017 May; 8(21):35473-35479. PubMed ID: 28415674 [TBL] [Abstract][Full Text] [Related]
23. [Association of Semaphorin 3A with thrombocytopenia in systemic lupus erythematosus]. Guo Q; Ma XX; Gao H; Shi LJ; Zhong YC; Xie LF; Shao M; Zhang XW Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):892-896. PubMed ID: 33047725 [TBL] [Abstract][Full Text] [Related]
24. Quantitative immunohistologic criteria are superior to the lymphocytic focus score criterion for the diagnosis of Sjögren's syndrome. Bodeutsch C; de Wilde PC; Kater L; van Houwelingen JC; van den Hoogen FH; Kruize AA; Hené RJ; van de Putte LB; Vooijs GP Arthritis Rheum; 1992 Sep; 35(9):1075-87. PubMed ID: 1418024 [TBL] [Abstract][Full Text] [Related]
25. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis. Beckman KA; Luchs J; Milner MS; Ambrus JL Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891 [TBL] [Abstract][Full Text] [Related]
26. Elevated IgG4 serum levels among primary Sjögren's syndrome patients: do they unmask underlying IgG4-related disease? Mavragani CP; Fragoulis GE; Rontogianni D; Kanariou M; Moutsopoulos HM Arthritis Care Res (Hoboken); 2014 May; 66(5):773-7. PubMed ID: 25100215 [TBL] [Abstract][Full Text] [Related]
28. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome]. Ampélas JF; Wattiaux MJ; Van Amerongen AP Encephale; 2001; 27(6):588-99. PubMed ID: 11865567 [TBL] [Abstract][Full Text] [Related]
29. Vasculitis and expression of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and E-selectin in salivary glands of patients with Sjögren's syndrome. Turkcapar N; Sak SD; Saatci M; Duman M; Olmez U J Rheumatol; 2005 Jun; 32(6):1063-70. PubMed ID: 15940769 [TBL] [Abstract][Full Text] [Related]
30. The Prevalence of Sjögren's Syndrome in Rheumatoid Arthritis Patients and Their Clinical Features. Kim H; Cho SK; Kim HW; Han J; Kim Y; Hwang KG; Sung YK J Korean Med Sci; 2020 Nov; 35(45):e369. PubMed ID: 33230982 [TBL] [Abstract][Full Text] [Related]
31. SS-A/Ro antibodies in Chinese patients with systemic lupus erythematosus and Sjögren's syndrome. Tsay GJ; Wang CL; Chen TY; Huang CN; Hsu TC J Formos Med Assoc; 1996 Dec; 95(12):905-10. PubMed ID: 9000806 [TBL] [Abstract][Full Text] [Related]
32. Sjogren's syndrome in SLE: Part I. The frequency of the clinical and subclinical features of Sjogren's syndrome in patients with SLE. Grennan DM; Ferguson M; Williamson J; Mavrikakis M; Dick WC; Buchanan WW N Z Med J; 1977 Oct; 86(598):374-6. PubMed ID: 272546 [TBL] [Abstract][Full Text] [Related]
33. Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes. Mavragani CP; Nezos A; Sagalovskiy I; Seshan S; Kirou KA; Crow MK J Autoimmun; 2018 Mar; 88():75-82. PubMed ID: 29074164 [TBL] [Abstract][Full Text] [Related]
34. Evidence for the Detection of Subclinical Retinal Involvement in Systemic Lupus Erythematosus and Sjögren Syndrome: A Potential Association with Therapies. Conigliaro P; Triggianese P; Draghessi G; Canofari C; Aloe G; Chimenti MS; Valeri C; Nucci C; Perricone R; Cesareo M Int Arch Allergy Immunol; 2018; 177(1):45-56. PubMed ID: 29902805 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of Epratuzumab, an Anti-CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the EMBODY Trials. Gottenberg JE; Dörner T; Bootsma H; Devauchelle-Pensec V; Bowman SJ; Mariette X; Bartz H; Oortgiesen M; Shock A; Koetse W; Galateanu C; Bongardt S; Wegener WA; Goldenberg DM; Meno-Tetang G; Kosutic G; Gordon C Arthritis Rheumatol; 2018 May; 70(5):763-773. PubMed ID: 29381843 [TBL] [Abstract][Full Text] [Related]
36. Clinical features and risk factors of neurological involvement in Sjögren's syndrome. Ye W; Chen S; Huang X; Qin W; Zhang T; Zhu X; Zhu X; Lin C; Wang X BMC Neurosci; 2018 Apr; 19(1):26. PubMed ID: 29703151 [TBL] [Abstract][Full Text] [Related]
37. Sicca symptoms and secondary Sjögren's syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables. Gilboe IM; Kvien TK; Uhlig T; Husby G Ann Rheum Dis; 2001 Dec; 60(12):1103-9. PubMed ID: 11709451 [TBL] [Abstract][Full Text] [Related]
38. Light microscopy of dried saliva in the evaluation of xerostomia of the sicca syndrome. A preliminary report. Andonopoulos AP; Tzanakakis GN; Christophidou M J Rheumatol; 1992 Sep; 19(9):1390-2. PubMed ID: 1433006 [TBL] [Abstract][Full Text] [Related]